Integra has completed their internal investigation on january 20, 2017.The investigation included: methods: review of device history records.Review of complaints history.Results: the unit will not be returned since it was implanted in the patient.Dhr review; ten (10) retain sample units were visually inspected for product and packaging appearance, including labeling.No anomalies were observed.All units met product and packaging specifications according to ¿packaged collagen product inspection¿.Complaints history; no similar complaints related to ¿expired product implanted¿ have been reported for this fg lot 1140945.Approximately (b)(4) units of neuragen products have been shipped for sales purposes since december 2014 until december 2016, resulting in a complaint occurrence rate of approximately(b)(4).Conclusion: (root/cause) the reported incident (expired product implanted) could not be associated to the manufacturing / packaging process performed.Complaint unit was labeled in an accurate manner and applicable procedures.The packaged product had several labels that contained the expiration date that are very noticeable by the end user, therefore the reported incident could be associated to inappropriate handling of the product (product misuse) by the reporting facility.
|